Rasagiline Evopharm Tablets 1mg Malta - English - Medicines Authority

rasagiline evopharm tablets 1mg

evopharm s.r.o vyšehradská 12 bratislava, 851 06, slovakia - rasagiline - tablet - rasagiline 1 mg - anti-parkinson drugs

ROCURONIUM BROMIDE- rocuronium bromide injection United States - English - NLM (National Library of Medicine)

rocuronium bromide- rocuronium bromide injection

solupharm pharmazeutische erzeugnisse gmbh - rocuronium bromide (unii: i65mw4ofhz) (rocuronium - unii:wre554rfez) - rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. rocuronium bromide is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [see warnings and precautions (5.2)] . developmental toxicology studies have been performed with rocuronium bromide in pregnant, conscious, nonventilated rabbits and rats. inhibition of neuromuscular function was the endpoint for high-dose selection. the maximum tolerated dose served as the high dose and was administered intravenously 3 times a day to rats (0.3 mg/kg, 15%-30% of human intubation dose of 0.6-1.2 mg/kg based on the body surface unit of mg/m 2 ) from day 6 to 17 and to rabbits (0.02 mg/kg, 25% human dose) from day 6 to 18 of pregnancy. high-dose treatment caused acute symptoms of

ACETAMINOPHEN injection, solution United States - English - NLM (National Library of Medicine)

acetaminophen injection, solution

solupharm pharmazeutische erzeugnisse gmbh - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - acetaminophen injection is indicated for - the management of mild to moderate pain in adult and pediatric patients 2 years and older - the management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older - the reduction of fever in adult and pediatric patients. acetaminophen is contraindicated: - in patients with known hypersensitivity to acetaminophen or to any of the excipients in the intravenous formulation. - in patients with severe hepatic impairment or severe active liver disease [see warnings and precautions (5.1)] . risk summary published epidemiological studies with oral acetaminophen use during pregnancy have not reported a clear association with acetaminophen use and birth defects, miscarriage, or adverse maternal or fetal outcomes [see data] . animal reproduction studies have not been conducted with iv acetaminophen. reproductive and developmen